Navigation Links
Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
Date:4/3/2008

us, the relative risk of death increases by 6 percent.

Hyperphosphatemia is managed with a combination of dialysis, diet restriction, and phosphorus-binding agents, because diet and dialysis alone generally cannot adequately control phosphorus levels. Such binders "soak up" phosphorus in the gastrointestinal tract, before it can be absorbed into the blood, and aid patients in maintaining acceptable levels of mean serum phosphorus.

FOSRENOL

FOSRENOL is indicated to reduce serum phosphate in patients with end-stage renal disease (ESRD).

FOSRENOL is an effective, noncalcium, nonresin phosphate binder that reduces high phosphorus levels in CKD Stage 5 patients. FOSRENOL is formulated as an easy-to-use, unflavored, chewable tablet that can be taken without water, an important consideration for CKD Stage 5 patients who must restrict their fluid intake.

FOSRENOL is available in a broad range of dosage strengths, including 500- mg, 750-mg and 1-g tablets. Patients taking FOSRENOL can achieve serum phosphorus target levels with as few as three tablets per day.*

FOSRENOL has the lowest pill burden of all phosphate binders, which may aid in adherence and reduce treatment costs.

The active ingredient in FOSRENOL is lanthanum, which has a high PBR. In addition, the binding power of FOSRENOL, in vitro, was not compromised by pH variations throughout the gastrointestinal tract.

FOSRENOL has a high affinity for phosphate and works by binding to dietary phosphorus in the gastrointestinal tract. Once bound, the FOSRENOL/phosphorus complex cannot pass into the bloodstream and is eliminated from the body, thereby decreasing mean serum phosphorus levels.

The safety of FOSRENOL has been studied in over 5,500 patients. Despite the challenge of CKD Stage 5 mortality for long-term data, a number of patients (N=22) taking FOSRENOL have been followed for more than 5 years. In addition, more than 87,000 patients have been prescribe
'/>"/>

SOURCE Shire Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Orqis(R) Medicals Cancion(R) System Significantly Increases Cardiac Performance
2. New Data Shows Ranexa(R) Increases Glucose-Stimulated Insulin Secretion
3. New Michael J. Fox Foundation Initiative Will Drive Development of Web-Based Tools to Increase Patient Participation in Parkinsons Clinical Trials
4. Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen(R) Technology at Lower Doses
5. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
6. Bone Mineral Content Continues to Increase in Obese Adolescents During Weight Loss
7. Study Linking Increased Risk of Death to Severe Psoriasis a Call to Action
8. FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
9. FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
10. Data Presented at the American Heart Association Scientific Sessions 2007 Demonstrated Increased HDL with ACTOS(R) (pioglitazone HCl) Slowed the Progression of Carotid Intima-Media Thickness in Patients with Type 2 Diabetes
11. Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... /PRNewswire-iReach/ -- Gateway Analytical announced today that they ... Annual Global Pharma Manufacturing Summit in ... The Global Pharma Manufacturing Summit offers a networking ... biologic pharmaceutical manufacturing. The conference is focused on ... such as the increasing pressure to grow and ...
(Date:8/28/2014)... Telik, Inc. (OTCQB: TELK), a clinical ... MabVax Therapeutics, Inc. on July 8, 2014, announced ... the development of its lead antibody program designated ... Company,s internally developed antibody discovery platform.  These preclinical ... based therapeutic and diagnostic products based on this ...
(Date:8/28/2014)... 2014  Rx Safes, Inc., the manufacturer of fingerprint ... waging a new war on drugs to reduce prescription ... More than 2,500 children a day experiment with ... are easily accessed from unsecured medicine cabinets, closets and drawers. ... streets, Rx Safes will address the new age drug ...
Breaking Medicine Technology:Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 2Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 4Rx Safes, Inc. Announces New War On Drugs 2
... Study of Zalutumumab in Combination, With Radiotherapy ... COPENHAGEN, June 24 Genmab A/S (OMX: GEN),announced ... zalutumumab,(HuMax-EGFr(TM)) in combination with radiotherapy for the treatment of,advanced ... maximum of 36,patients who are ineligible for platinum based ...
... New Recommendations Address Presurgery and Pediatric Dilemmas, ... evidence-based guidelines,address the prevention and management of ... related to the routine use of,preventive therapies. ... issue of CHEST,the peer-reviewed journal of the ...
Cached Medicine Technology:Genmab Initiates Study of Zalutumumab With Radiotherapy in Head and Neck Cancer 2Genmab Initiates Study of Zalutumumab With Radiotherapy in Head and Neck Cancer 3Thrombosis Guidelines Emphasize Difficult Choices for Pregnant Women 2Thrombosis Guidelines Emphasize Difficult Choices for Pregnant Women 3Thrombosis Guidelines Emphasize Difficult Choices for Pregnant Women 4
(Date:8/28/2014)... To kick off the fall season ... One Spas retailers across the country are offering 0% ... The Hot Tub Tailgate Event is from August 29th-September ... more information and to apply early! , As the ... wide variety of outdoor hot tubs with exclusive features ...
(Date:8/28/2014)... Somerset, N.J. (PRWEB) August 28, 2014 ... of advanced delivery technologies and development solutions for ... that Kristen DeVito, Global Director Clinical Supply Services, ... will present “Critical Path Sourcing Strategies for Active ... Trials Supply Conference, which takes place on the ...
(Date:8/28/2014)... nasal septum cells. Researchers at the University and the ... the nasal septum are able to adapt to the ... articular cartilage defects. The nasal cartilage cells, ability to ... with the expression of so-called HOX genes. The scientific ... research results together with the report of the first ...
(Date:8/28/2014)... who identify themselves as ,old, feel worse about their ... lower value than younger age groups. , New research ... old and ill, across different countries: social status, age ... the European Social Survey. Respondents, who were all aged ... The researchers found that those living in societies where ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 BCC Research ... SURGICAL NAVIGATION SYSTEMS: TECHNOLOGIES AND GLOBAL MARKETS , the ... $419.7 million in 2013. Driven by the need for ... medical tourism in emerging geographies, the market is expected ... growth rate (CAGR) of 8.5% from 2013 through 2018. ...
Breaking Medicine News(10 mins):Health News:Critical Path Sourcing Strategies for Global Clinical Trials Presented by Catalent Experts at US Clinical Trials Supply Conference 2Health News:From nose to knee: Engineered cartilage regenerates joints 2Health News:Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR 2Health News:Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR 3
... In order to expand the range and reach of its affiliate ... Network this February. This is in addition to the company,s already ... ... Diego, CA (PRWEB) March 26, 2009 -- In order to expand ...
... a protein that helps prevent tumours spreading and growing ... many different types of cancer. In a study published ... , Canadian researchers modified the tumour inhibiting protein, von ... growth in mice. , When solid tumours grow they ...
... March 25 While dollars for infrastructure and construction ... becoming known that nearly $22 billion in stimulus funds ... across the nation. As the federal government works to ... Reinvestment Act of 2009 will be allocated, ...
... The U.S. Agency for International Development,s (USAID) ... providing more than $3.7 million in assistance to ... of families in Senegal.Of this $3.7 million, USAID ... efforts and agriculture production in the regions of ...
... The California Transplant Donor Network today issued the following statement on ... the line of duty: "Our hearts go out to the family ... community. Officer Hege was registered on the Donate Life California ... chose in death as he did in life to help those ...
... Demonstration on Anakam,s Authentication SolutionsSAN DIEGO, March 25 Anakam,s ... John Macaulay will be giving a presentation on two-factor authentication ... Place. The presentation will take place at 4:15 p.m. ... discussing issues healthcare faces in the age of electronic health ...
Cached Medicine News:Health News:TestCountry.com Expands Its Affiliate Reach with Google Affiliate Network 2Health News:TestCountry.com Expands Its Affiliate Reach with Google Affiliate Network 3Health News:Bioengineered proteins: Trial confirms new way to tackle cancer 2Health News:GlobalMedia Provides Free Grant Writing and Application Assistance to Healthcare Providers and Professionals Seeking Their Share of Billions in Economic Stimulus Dollars 2Health News:California Transplant Donor Network Issues Statement on Officer John Hege's Donation 2Health News:Dr. William 'Bill' Braithwaite and Dr. John Macaulay Present Anakam's Two-Factor Authentication Platform at HIMSS 2009 Annual Conference and Exhibition 2
BETADINE Solution Swab Aid antiseptic pads are for quick and easy skin degerming. Individually wrapped pads, saturated with 10% povidone-iodine solution, offer the advantages of BETADINE Solution in ...
IV Prep Swab Sticks are effective, easy to apply, dries quickly and reduces bacterial contaminations. They are ideal for preparation of the skin prior to a ventipuncture or injection....
BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness....
BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness....
Medicine Products: